Chapter 30
Role of Excipients in formulation development and biocompatibility of lipid nanoparticles (SLNs/NLCs)
Slavomira Doktorovova*
Ranjita Shegokar**
Abstract
Lipid nanoparticles are widely explored in many therapeutic, targeting, and imaging areas. Among the various nanoplatforms, lipid-based nanostructures offer better attributes to drug delivery, such as high loading capacity, biocompatibility, improved physicochemical and long-term stability, ease of surface modification, adjustable drug release, and enhanced bioavailability. Despite the extensive number of publications focusing on the development of lipid nanoparticles, very limited ...
Get Nanostructures for Novel Therapy now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
